IBJNews

Lilly diabetes pill recommended for EU approval

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. and Boehringer Ingelheim GmbH’s Trajenta medicine for Type 2 diabetes has been recommended for approval in Europe, putting the drug on track to enter the region’s market this year.

The European Medicines Agency’s Committee for Medicinal Products for Human Use said Trajenta should be used in patients whose diabetes can’t be controlled by diet and exercise alone and who can’t take the older medication metformin, Boehringer said in a statement Friday.

Known chemically as linagliptin, the pill was approved in May by regulators in the U.S., where it’s marketed under the spelling Tradjenta. The drug is among four diabetes treatments Indianapolis-based Lilly and Ingelheim, Germany-based Boehringer agreed in January to develop and sell jointly, sharing equally in costs and margins from the products.

The drug can be an “important new treatment option” for patients with Type 2 diabetes, Enrique Conterno, president of Lilly’s diabetes division, said in the prepared statement.

The Boehringer partnership may contribute to earnings by 2014, Lilly said when the deal was announced. Sales of each drug may be about $2.84 billion, and combined peak sales may reach $14.2 billion, Engelbert Tjeenk Willink, the Boehringer executive responsible for human pharmaceutical products’ sales and marketing, said at the time.

More than 220 million people worldwide have diabetes, and about 90 percent have the Type 2 version, according to the World Health Organization. Obese people are among the most at risk for the disease, which prevents the body from using insulin properly to control blood glucose levels. Left untreated, Type 2 diabetes can lead to heart attack, stroke and blindness.

The European Medicines Agency, based in London, provides initial regulatory authorization for treatments from companies seeking regionwide approval in all European Union countries plus Iceland, Liechtenstein and Norway. The European Commission, the EU’s executive arm, gives final approval based on the agency’s recommendation.

Lilly stock fell 29 cents Friday morning, to $36.90 per share.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. We gotta stop this Senior crime. Perhaps long jail terms for these old boozers is in order. There are times these days (more rather than less) when this state makes me sick.

  2. One option is to redistribute the payroll tax already collected by the State. A greater share could be allocated to the county of the workplace location as opposed to the county of residency. Not a new tax, just re-allocate what is currently collected.

  3. Have to agree with Mal Burgess. The biggest problem is massive family breakdown in these neighborhoods. While there are a lot of similiarities, there is a MASSIVE difference between 46218 and 46219. 46219 is diluted by some stable areas, and that's probably where the officers live. Incentivizing is fine, but don't criticize officers for choosing not to live in these neighbor hoods. They have to have a break from what is arguably one of the highest stress job in the land. And you'll have to give me hard evidence that putting officers there is going to make a significant difference. Solid family units, responsible fathers, siblings with the same fathers, engaged parents, commitment to education, respect for the rule of law and the importance of work/a job. If the families and the schools (and society) will support these, THEN we can make a difference.

  4. @Agreed, when you dine in Marion County, the taxes paid on that meal go to state coffers (in the form of the normal sales taxes) and to the sports/entertainment venues operated by the CIB. The sales taxes on your clothing and supplies just go to the state. The ONLY way those purchases help out Indianapolis is through the payroll taxes paid by the (generally low-wage) hourly workers serving you.

  5. The government leaders of Carmel wouldn't last a week trying to manage Indianapolis. There's a major difference between running a suburb with virtually no one below the poverty level and running a city in which 21+% are below the poverty level. (http://www.census.gov/did/www/saipe/data/interactive/#view=StateAndCounty&utilBtn=&yLB=0&stLB=15&cLB=49&dLB=0&gLB=0&usSts_cbSelected=false&usTot_cbSelected=true&stateTot_cbSelected=true&pLB=0?ltiYearSelected=false?ltiYearAlertFlag=false?StateFlag=false?validSDYearsFlag=false)

ADVERTISEMENT